Literature DB >> 25727963

Role of the 5-HT1A autoreceptor in the enhancement of fluvoxamine-induced increases in prefrontal dopamine release by adrenalectomy/castration in mice.

Shigeru Hasebe1, Naoki Hiramatsu1, Yukio Ago1, Kazuya Mori1, Yuji Watabe1, Hitoshi Hashimoto2, Kazuhiro Takuma3, Toshio Matsuda4.   

Abstract

We have found that fluvoxamine-induced increases in prefrontal dopamine release are enhanced by adrenalectomy/castration and 5-HT1A receptors are involved in the enhancement. This study examined which 5-HT1A autoreceptors or postsynaptic receptor play a key role in the enhancement in mice. Adrenalectomy/castration-induced enhancement of fluvoxamine-induced increase in the dopamine release was not blocked by local perfusion with the 5-HT1A receptor antagonist WAY100635 (10 μM), while it was blocked by systemic administration of WAY100635 at low dose (0.1 mg/kg) which blocked preferentially autoreceptor-mediated responses. These finding suggests that 5-HT1A autoreceptors play a key role in the enhancement of prefrontal dopamine release.
Copyright © 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-HT(1A) autoreceptor; Prefrontal dopamine release; WAY100635

Mesh:

Substances:

Year:  2015        PMID: 25727963     DOI: 10.1016/j.jphs.2015.01.001

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  2 in total

1.  Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice.

Authors:  S Hasebe; Y Ago; Y Watabe; S Oka; N Hiramatsu; T Tanaka; C Umehara; H Hashimoto; K Takuma; T Matsuda
Journal:  Br J Pharmacol       Date:  2017-01-26       Impact factor: 8.739

2.  Involvement of GABAA receptors in 5-HT1A and σ1 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.

Authors:  Yukio Ago; Shigeru Hasebe; Naoki Hiramatsu; Kazuya Mori; Yuji Watabe; Yusuke Onaka; Hitoshi Hashimoto; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2016-06-23       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.